DIABELOOP

DIABELOOP est membre de Lyonbiopôle

General information

Incorporated in: 2015/03/24

Number of employees: 20


More information

 

Main activity

Diabeloop is developing an artificial pancreas, that will enable people with Type 1 Diabetes to better manage their disease.


Funding

Private funding obtained: €7.5 million of equity (summer 2017) €1 million of bank credit

Public funding obtained: €5 million (Bpifrance)

Segmentation
Activities
Products / Services / Technologies

Strategic area of application
Medical Technologies


Application market
Endocrinology


Activities
Medical device


Technologies
Drug delivery device - services - Disposable & Implants